157 related articles for article (PubMed ID: 20597919)
1. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
[TBL] [Abstract][Full Text] [Related]
2. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
Broide E; Zeigler M; Eckstein J; Bach G
Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
[TBL] [Abstract][Full Text] [Related]
3. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
[TBL] [Abstract][Full Text] [Related]
4. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
Zlotogora J; Leventhal A
Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
[TBL] [Abstract][Full Text] [Related]
5. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Tay-Sachs disease screening program.
Gason AA; Sheffield E; Bankier A; Aitken MA; Metcalfe S; Barlow Stewart K; Delatycki MB
Clin Genet; 2003 May; 63(5):386-92. PubMed ID: 12752571
[TBL] [Abstract][Full Text] [Related]
7. Tay-Sachs disease as a model for screening inborn errors.
Blitzer MG; McDowell GA
Clin Lab Med; 1992 Sep; 12(3):463-80. PubMed ID: 1355703
[TBL] [Abstract][Full Text] [Related]
8. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
9. Knowledge about and attitudes toward genetic screening among high-school students: the Tay-Sachs experience.
Clow CL; Scriver CR
Pediatrics; 1977 Jan; 59(1):86-90. PubMed ID: 840547
[TBL] [Abstract][Full Text] [Related]
10. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
11. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
[TBL] [Abstract][Full Text] [Related]
12. Tay-Sachs disease carrier screening: a 21-year experience.
D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
[TBL] [Abstract][Full Text] [Related]
13. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
Laberge AM; Watts C; Porter K; Burke W
Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
[TBL] [Abstract][Full Text] [Related]
14. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
[No Abstract] [Full Text] [Related]
15. Knowledge and attitudes toward Tay-Sachs disease among a college student population.
Austein CF; Seashore MR; Mick SS
Yale J Biol Med; 1981; 54(5):345-54. PubMed ID: 7336765
[TBL] [Abstract][Full Text] [Related]
16. Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.
Triggs-Raine BL; Feigenbaum AS; Natowicz M; Skomorowski MA; Schuster SM; Clarke JT; Mahuran DJ; Kolodny EH; Gravel RA
N Engl J Med; 1990 Jul; 323(1):6-12. PubMed ID: 2355960
[TBL] [Abstract][Full Text] [Related]
17. DNA-based carrier screening in the Ashkenazi Jewish population.
Zhang B; Dearing L; Amos J
Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
[TBL] [Abstract][Full Text] [Related]
18. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
[TBL] [Abstract][Full Text] [Related]
19. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
[TBL] [Abstract][Full Text] [Related]
20. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
Delatycki MB
Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
